Guava Technologies
Latest round
- Series D
Last raised
- Dec 2003
Total raised
- $27M
Investors
- 9
About Guava Technologies
Guava Technologies specializes in cell analysis solutions with a focus on advanced flow cytometry systems. The company is based in Hayward, US.Guava Technologies offers innovative cell analysis solutions through its advanced full spectrum flow cytometry systems. Key products include the Cytek Aurora™ and Cytek Northern Lights™, enabling researchers to perform multiplexed experiments with up to 40 colors simultaneously.Guava Technologies generates revenue through direct sales of its flow cytometry systems and associated reagents, focusing on B2B transactions with research institutions. Their product offerings include consumables and hardware, with flagship products like the Cytek Aurora™ driving sales. The company plans to expand into new geographic regions and enhance its product line, although specific markets and release dates have not been disclosed.
Who invested in Guava Technologies
9 investors across 1 round
See all investors in Guava Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 18, 2003
Amount
$27M
Investors
Questions about Guava Technologies
Who invested in Guava Technologies?
Guava Technologies has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guava Technologies raised?
Guava Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Guava Technologies last raise money?
Guava Technologies's most recent round on record is a Series D, in Dec 2003.
What does Guava Technologies do?
Guava Technologies specializes in cell analysis solutions with a focus on advanced flow cytometry systems.
Where is Guava Technologies headquartered?
Guava Technologies is headquartered in Hayward, US.
Which VCs invest in companies like Guava Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Guava Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Guava Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.